Atlas FDA

MAESTRO RECHARGEABLE SYSTEM

FDA premarket approval P130019 · decided 2015-01-14

Approval details

PMA number
P130019
Trade name
MAESTRO RECHARGEABLE SYSTEM
Generic name
neuromodulator for obesity
Applicant
Reshape Lifesciences, Inc.
Date received
2013-06-21
Decision date
2015-01-14
Days to decision
572 days
Decision code
APWD
Product code
PIM
Advisory committee
Gastroenterology, Urology
Expedited review
No
Location
Roseville, MN
Statement
APPROVAL FOR THE MAESTRO® RECHARGEABLE SYSTEM. THIS DEVICE IS INDICATED FOR USE IN WEIGHT REDUCTION IN PATIENTS AGED 18 YEARS THROUGH ADULTHOOD WHO HAVE A BODY MASS INDEX (BMI) OF 40 TO 45 KG/M2, OR A BMI OF 35 TO 39.9 KG/M2 WITH ONE OR MORE OBESITY RELATED CO-MORBID CONDITIONS, AND HAVE FAILED AT LEAST ONE SUPERVISED WEIGHT MANAGEMENT PROGRAM WITHIN THE PAST FIVE YEARS.

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.